Cornelia L Trimble


1991 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Cornelia L Trimble is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Human papillomavirus 16 Medicine & Life Sciences
Papillomavirus Vaccines Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
DNA Vaccines Medicine & Life Sciences
Vaccination Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences
Cervical Intraepithelial Neoplasia Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2018

A primary role for human central memory cells in tissue immunosurveillance

Gehad, A., Teague, J. E., Matos, T. R., Huang, V., Yang, C., Watanabe, R., O'Malley, J. T., Trimble, C. L., Kupper, T. S. & Clark, R. A., Feb 13 2018, In : Blood advances. 2, 3, p. 292-298 7 p.

Research output: Contribution to journalArticle

Immunologic Monitoring
Cervix Uteri

Clinical and immunologic biomarkers for histologic regression of high-grade cervical dysplasia and clearance of HPV16 and HPV18 after immunotherapy

Morrow, M. P., Kraynyak, K. A., Sylvester, A. J., Dallas, M., Knoblock, D., Boyer, J. D., Yan, J., Vang, R. S., Khan, A. S., Humeau, L., Sardesai, N. Y., Kim, J. J., Plotkin, S., Weiner, D. B., Trimble, C. L. & Bagarazzi, M. L., Jan 15 2018, In : Clinical Cancer Research. 24, 2, p. 276-294 19 p.

Research output: Contribution to journalArticle

Uterine Cervical Dysplasia
Immunosuppressive Agents

Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model

Jin, B. Y., Campbell, T. E., Draper, L. M., Stevanović, S., Weissbrich, B., Yu, Z., Restifo, N. P., Rosenberg, S. A., Trimble, C. L. & Hinrichs, C. S., Apr 19 2018, In : JCI insight. 3, 8

Research output: Contribution to journalArticle

Open Access
T-Cell Antigen Receptor
Human papillomavirus 16
Uterine Cervical Neoplasms

HLA and KIR Associations of Cervical Neoplasia

Bao, X., Hanson, A. L., Madeleine, M. M., Wang, S. S., Schwartz, S. M., Newell, F., Pettersson-Kymmer, U., Hemminki, K., Tiews, S., Steinberg, W., Rader, J. S., Castro, F., Safaeian, M., Franco, E. L., Coutlée, F., Ohlsson, C., Cortes, A., Marshall, M., Mukhopadhyay, P., Cremin, K. & 14 others, Johnson, L. G., Garland, S. M., Tabrizi, S. N., Wentzensen, N., Sitas, F., Trimble, C. L., Little, J., Cruickshank, M., Frazer, I. H., Hildesheim, A., Brown, M. A., Duncan, E. L., Sun, Y. P. & Leo, P. J., Nov 5 2018, In : The Journal of infectious diseases. 218, 12, p. 2006-2015 10 p.

Research output: Contribution to journalArticle

KIR Receptors
HLA Antigens
Odds Ratio

Human papilloma virus-specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patients

McCormack, S. E., Cruz, C. R. Y., Wright, K. E., Powell, A. B., Lang, H., Trimble, C. L., Keller, M. D., Fuchs, E. J. & Bollard, C. M., Jan 1 2018, (Accepted/In press) In : Cytotherapy.

Research output: Contribution to journalArticle

Immunocompromised Host
Tissue Donors
Human Herpesvirus 4